Insider · CIK 0001654435
Asaf Danziger
Files at NVCR (NovoCure Ltd). First filing -, latest -.
Asaf Danziger files SEC Form 4 as director at NVCR (NovoCure Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Asaf Danziger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +833 | $15.13 | $13k | 416,473 | Jul 1, 2025 |
| Dec 31, 2024 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +412 | $14.75 | $6,076 | 15,640 | Jan 3, 2025 |
| Jan 1, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +400,000 | $0.00 | $0 | 415,640 | Jan 3, 2025 |
Questions about Asaf Danziger
Answered from the filings on this page, as of the latest one.
Is Asaf Danziger buying or selling?
Asaf Danziger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Asaf Danziger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Asaf Danziger has 0.
Where does Asaf Danziger file Form 4?
Asaf Danziger has filed Form 4 at NVCR (NovoCure Ltd). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.